SCHEMBL18976050

SCHEMBL18976050

CCn1c(=O)ccn(-c2ccc(F)cc2)c1=O

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 3/20 0.46
▸ ALDH1A1 P00352 3/20 0.46
▸ MAPT P10636 2/20 0.46
▸ HPGD P15428 2/20 0.46
▸ NPC1 O15118 1/20 0.46
▸ TSHR P16473 1/20 0.46
▸ ALOX12 P18054 1/20 0.46
▸ RAB9A P51151 1/20 0.46
▸ SMN1; SMN2 Q16637 1/20 0.46
▸ HSD17B10 Q99714 1/20 0.46
▸ RGS4 P49798 1/20 0.38
▸ RGS8 P57771 1/20 0.38
▸ GRM3 Q14832 1/20 0.38
▸ CDK4 P11802 1/20 0.37
▸ CCND1 P24385 1/20 0.37
▸ CCND2 P30279 1/20 0.37
▸ CCND3 P30281 1/20 0.37
▸ HTT P42858 1/20 0.36
▸ NCOA3 Q9Y6Q9 1/20 0.36
▸ MCHR1 Q99705 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10465163 0.83 ALDH1A1 (0.42) KDM4EALDH1A1MAPTHPGDNPC1
SCHEMBL16364510 0.79 GSK3A (0.43) KDM4EALDH1A1GRM3MCHR1
SCHEMBL10465429 0.78 CYP1A2 (0.49) ALDH1A1MAPTSMN1; SMN2HTT
SCHEMBL29703128 0.75 GSK3A (0.43) GRM3MCHR1
SCHEMBL19426961 0.75 ALDH1A1 (0.37) KDM4EALDH1A1MAPTHPGDNPC1
SCHEMBL16701744 0.73 CMA1 (0.47) —
SCHEMBL16352665 0.73 ALDH1A1 (0.46) KDM4EALDH1A1HPGDGRM3
SCHEMBL19993098 0.73 GSK3A (0.36) GRM3MCHR1
SCHEMBL19155336 0.73 ALDH1A1 (0.36) KDM4EALDH1A1MAPTHPGDNPC1
SCHEMBL16863292 0.70 GSK3A (0.42) KDM4EALDH1A1NPC1RGS4RGS8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180079758-A1 SUBSTITUTED TETRAHYDROCARBAZOLE AND CARBAZOLE CARBOXAMIDE COMPOUNDS BRISTOL MYERS SQUIBB CO (US) 2018-03-22 — — US disclosed
US-9850258-B2 Substituted tetrahydrocarbazole and carbazole carboxamide compounds BRISTOL-MYERS SQUIBB COMPANY (US) 2017-12-26 — — US disclosed
EP-3013814-B1 SUBSTITUTED TETRAHYDROCARBAZOLE AND CARBAZOLE CARBOXAMIDE COMPOUNDS USEFUL AS KINASE INHIBITORS BRISTOL MYERS SQUIBB CO (US) 2017-06-14 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180079758-A1 SUBSTITUTED TETRAHYDROCARBAZOLE AND CARBAZOLE CARBOXAMIDE COMPOUNDS BTK, CNKSR1, JAK2 KDM4E 535/4885ALDH1A1 3286/4885MAPT 4755/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback